Form 4: Dynavax Technologies SVP John Slebir Reports Stock Transactions
SEC Form 4 Filing
John Slebir, SVP General Counsel of Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding, along with shares acquired through the Employee Stock Purchase Plan.
Summary
- On February 10, 2025, John Slebir, SVP General Counsel of Dynavax Technologies, reported transactions involving Dynavax common stock.
- 4,666 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of common stock.
- Simultaneously, 1,747 shares were withheld by Dynavax to satisfy tax obligations related to the vesting of these RSUs at a price of $13.2 per share.
- Slebir also acquired 1,393 shares under the company's Employee Stock Purchase Plan (ESPP) on August 15, 2024.
- Following these transactions, Slebir directly owns 14,397 shares of Dynavax common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions. The vesting of RSUs is a positive sign, but the tax withholding is a neutral event.
Positives
- The vesting of RSUs and participation in the ESPP indicate Slebir's continued investment in Dynavax Technologies.
Negatives
- The withholding of shares to cover tax obligations reduces the net increase in Slebir's holdings.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market regarding the buying and selling activities of company executives and directors.
Comparison to Industry Standards
- Insider transactions are routinely monitored across the biotechnology industry, with companies like Moderna (MRNA) and BioNTech (BNTX) also subject to similar reporting requirements.
- The vesting schedule of the RSUs (1/3 vesting annually over three years) is a common practice in executive compensation packages within the biotech sector, aligning executive incentives with long-term company performance.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider activity, but do not indicate a significant change in ownership or company outlook.
Key Dates
| Date | Description |
|---|---|
| February 10, 2022 | Initial vesting date for RSUs, vesting annually over three years. |
| August 15, 2024 | Date of acquisition of shares under the Employee Stock Purchase Plan. |
| February 10, 2025 | Date of RSU vesting and tax withholding. |
| February 12, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.